The article explains the differences between folate, folic acid, and folinic acid, emphasizing their roles in pregnancy and potential use in autism treatment. It warns against self-medicating with supplements like leucovorin for autism, highlighting that current evidence is limited and more research is needed. Medical experts advise caution due to regulatory differences and the complexity of autism, recommending consulting healthcare providers before use.
The FDA approved leucovorin, a vitamin B derivative, as a treatment for cerebral folate deficiency linked to autism, bypassing its usual rigorous approval process, which has raised concerns among experts about the premature endorsement and lack of dosage guidelines, emphasizing the need for further research.
U.S. Health Secretary Robert F. Kennedy Jr. is reportedly planning to suggest a potential link between Tylenol use during pregnancy and autism, though no scientific evidence has been provided. Kenvue, the maker of Tylenol, denies any causal connection, and major health authorities support the safety of acetaminophen during pregnancy. The report also mentions exploring folinic acid as a treatment for autism symptoms. The announcement has caused Kenvue's stock to fall, and the topic remains controversial amid ongoing research and legal debates.
